5-(6-METHYL-1H-BENZOIMIDAZOL-2-YLSULFANYL)-FURAN-2-CARBALDEHYDE
- $400 - $777.32
- Product name: 5-(6-METHYL-1H-BENZOIMIDAZOL-2-YLSULFANYL)-FURAN-2-CARBALDEHYDE
- CAS: 842957-71-5
- MF: C13H10N2O2S
- MW: 258.3
- EINECS:
- MDL Number:MFCD02629618
- Synonyms:TIMTEC-BB SBB012027;5-(6-METHYL-1H-BENZOIMIDAZOL-2-YLSULFANYL)-FURAN-2-CARBALDEHYDE;5-[(6-Methyl-2-benzimidazolyl)thio]furan-2-carbaldehyde;2-Furancarboxaldehyde, 5-[(6-methyl-1H-benzimidazol-2-yl)thio]-
3 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Matrix Scientific
Package
- 500MG
- 1g
- ManufacturerAK Scientific
- Product number0391AF
- Product description5-(6-Methyl-1H-benzoimidazol-2-ylsulfanyl)-furan-2-carbaldehyde
- Packaging1g
- Price$590
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0139804
- Product description5-(6-METHYL-1H-BENZOIMIDAZOL-2-YLSULFANYL)-FURAN-2-CARBALDEHYDE 95.00%
- Packaging500MG
- Price$777.32
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number018608
- Product description5-(6-Methyl-1H-benzoimidazol-2-ylsulfanyl)-furan-2-carbaldehyde
- Packaging1g
- Price$400
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 0391AF | 5-(6-Methyl-1H-benzoimidazol-2-ylsulfanyl)-furan-2-carbaldehyde | 1g | $590 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0139804 | 5-(6-METHYL-1H-BENZOIMIDAZOL-2-YLSULFANYL)-FURAN-2-CARBALDEHYDE 95.00% | 500MG | $777.32 | 2021-12-16 | Buy |
Matrix Scientific | 018608 | 5-(6-Methyl-1H-benzoimidazol-2-ylsulfanyl)-furan-2-carbaldehyde | 1g | $400 | 2021-12-16 | Buy |
Properties
Boiling point :521.4±60.0 °C(Predicted)
Density :1.41±0.1 g/cm3(Predicted)
pka :10.59±0.10(Predicted)
Density :1.41±0.1 g/cm3(Predicted)
pka :10.59±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|